You are here

hemophilia

U.S. FDA approves Biogen's hemophilia A drug Eloctate

Yahoo/Reuters

Sat, 06/7/14 - 08:59 am

Biogen, Sobi pledge hemophilia drug donation in developing world

Yahoo/Reuters

Mon, 05/12/14 - 08:21 am

Swedish Orphan Biovitrum

Exclusive: Biogen prices hemophilia drug on par with older therapies

Yahoo/Reuters

Sat, 04/19/14 - 10:02 am

Baxter snaps up its hemophilia partner on the verge of a biotech breakup

Fierce Biotech

Thu, 04/3/14 - 09:32 am

Baxter International

Chatham Therapeutics

Biogen Wins Approval for Long-Lasting Hemophilia B Treatment

Bloomberg

Sat, 03/29/14 - 09:10 am

Bayer to invest $700 mln to produce hemophilia drugs in Germany

Yahoo/Reuters

Tue, 03/11/14 - 03:05 pm

Bayer cites success in hemophilia study, but may still trail Biogen Idec

Fierce Biotech

Tue, 02/18/14 - 10:33 am

Cholesterol Drug From Trash Seen Preventing Heart Attack

Bloomberg

Wed, 11/20/13 - 11:57 am

Biogen’s Hemophilia Drug Delay May Push Sales to Mid-2014

Bloomberg

Tue, 11/12/13 - 01:09 pm

Alnylam's Biggest Opportunities

Motley Fool

Wed, 10/2/13 - 10:02 am

UK docs warned of hemophilia risk with Sanofi's clopidogrel

Pharma Times, UK

Tue, 09/17/13 - 09:40 am

Baxter snags hemophilia candidate in $185M deal with Ipsen and broke biotech

Fierce Biotech

Thu, 01/24/13 - 11:32 am

Baxter International

Baxter Announces Phase III Data Evaluating Prophylaxis Treatment of FEIBA NF for Hemophilia Patients with Inhibitors

Yahoo/BusinessWire

Tue, 01/8/13 - 10:43 pm

Baxter International

Baxter Announces Long-Term Partnership in Brazil to Expand Access to Recombinant FVIII Hemophilia Treatment

Thu, 11/1/12 - 10:16 pm

Biogen Hemophilia A Therapy Helps in Fewer Injections

Bloomberg

Wed, 10/31/12 - 11:37 am

Novo Nordisk halts development of hemophilia drug

Reuters

Fri, 09/28/12 - 12:11 pm

vatreptacog alfa

Biogen's New Hemophilia Drug Could Replace Pfizer's Old One

Forbes

Wed, 09/26/12 - 11:00 am

Baxter Submits Application for FDA Approval of Recombinant Factor IX for the Treatment of Hemophilia B

Wed, 09/5/12 - 09:52 pm

Bayer HealthCare to Present Data on Secondary Prophylaxis with Kogenate(R) FS -- antihemophilic factor (recombinant) on Bleeding Frequency in Adults and Adolescents with Severe Hemophilia A

PharmaLive

Sun, 07/15/12 - 12:10 pm

antihemophilic factor

Bayer Initiates Phase II/III Trial of New Recombinant Factor VIII Compound for Treatment of Hemophilia A

news.genom.es

Sun, 07/8/12 - 01:26 pm

Pages